Phathom Pharmaceuticals, Inc.PHATNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank14
3Y CAGR-22.9%
5Y CAGR-19.7%
Year-over-Year Change
Research and development spending
3Y CAGR
-22.9%/yr
vs +673.1%/yr prior
5Y CAGR
-19.7%/yr
Recent deceleration
Acceleration
-696.0pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
6 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $32.78M | -3.8% |
| 2024 | $34.08M | -31.7% |
| 2023 | $49.90M | -30.2% |
| 2022 | $71.44M | -1.2% |
| 2021 | $72.34M | -26.3% |
| 2020 | $98.15M | -1.1% |
| 2019 | $99.27M | +496255.0% |
| 2018 | $20000.00 | - |